76 results on '"Åsberg, Anders"'
Search Results
2. Very Low Frequency of Pathological Findings in One-year Protocol Biopsies of Uneventful Standard Risk Kidney Transplant Recipients: Results From the Nordic Protocol Biopsy Study
3. Long-term Kidney Transplant Survival Across the Globe
4. Trabecular Bone Score Improves Early After Successful Kidney Transplantation Irrespective of Antiresorptive Therapy and Changes in Bone Mineral Density
5. Humoral Response After 6 or More Successive Doses of SARS-CoV-2 mRNA Vaccines in Kidney Transplant Recipients—Should We Keep Vaccinating?
6. Humoral Response After 6 or More Successive Doses of SARS-CoV-2 mRNA Vaccines in Kidney Transplant Recipients—Should We Keep Vaccinating?
7. Klotho and Fibroblast Growth Factor 23 Are Independent of Vitamin D, and Unlike Vitamin D, Are Not Associated With Graft- and Patient Survival After Kidney Transplantation
8. Cytomegalovirus High-risk Kidney Transplant Recipients Show No Difference in Long-term Outcomes Following Preemptive Versus Prophylactic Management
9. Impact of Fasting Status and Circadian Variation on the Pharmacokinetics of Mycophenolate Mofetil and the Glucuronide Metabolite in Renal Transplant Recipients
10. Poor Physical Function Trajectory Predicts Impaired Patient Survival in Older Recipients of Deceased Donor Kidneys: A Prospective Cohort Study
11. 213.4: Single-dose Rituximab Induction May Prevent EBV Viremia in Paediatric Kidney Recipients Long-term: An Investigation From the Nordic Paediatric Renal Transplantatioinn Study Group
12. 213.3: Long-term Outcome and Complications in Pediatric ABO-incompatible Living Donor Kidney Transplantation With rituximab Induction: A Multi-centre Investigation From the Nordic Paediatric Renal Transplantation Study Group
13. Endothelial Dysfunction and 6-Year Risk of Mortality in Kidney Transplant Recipients
14. Posttransplant Hypertension Matters!
15. Prednisolone and Prednisone Pharmacokinetics in Adult Renal Transplant Recipients
16. The Authors’ Reply
17. Severe Mycophenolate Intoxication in a Solid Organ Transplant Recipient—No Intervention Actually Needed
18. The Authors’ Reply: Placental Pathology in Pregnancies After Kidney Transplantation
19. Tacrolimus Area Under the Concentration Versus Time Curve Monitoring, Using Home-Based Volumetric Absorptive Capillary Microsampling
20. Immunosuppression and Reproductive Health After Kidney Transplantation
21. Tacrolimus Can Be Reliably Measured With Volumetric Absorptive Capillary Microsampling Throughout the Dose Interval in Renal Transplant Recipients
22. Therapeutic Drug Monitoring of Tacrolimus-Personalized Therapy: Second Consensus Report
23. A Fully Automated Method for the Determination of Serum Belatacept and Its Application in a Pharmacokinetic Investigation in Renal Transplant Recipients
24. A rapid and sustained improvement of calcification propensity score (serum T50) after successful kidney transplantation: Reanalysis of a randomized controlled trial of ibandronate
25. Visceral fat is strongly associated with post‐transplant diabetes mellitus and glucose metabolism 1 year after kidney transplantation
26. Preserved Insulin Sensitivity and Kidney Function One Year After Successful Pancreas Transplantation
27. Use of Empagliflozin in Renal Transplant Recipients with Post Transplantation Diabetes Mellitus: Short Term Safety
28. Determination of Tacrolimus Concentration and Protein Expression of P-glycoprotein in Single Human Renal Core Biopsies
29. High-Dose Fish Oil Supplementation Increase Tacrolimus Exposure in Stable Renal Transplant Recipients
30. High Tacrolimus Clearance – A Risk Factor for Development of Interstitial Fibrosis and Tubular Atrophy in the Transplanted Kidney
31. Adherence to Immunosuppressive Medications in Renal Transplant Recipients – Different Tools Capture Different Patients
32. A Limited Sampling Strategy to Estimate Whole Blood and Intra-lymphocyte Exposure of Everolimus in Renal Transplant Recipients using Population Pharmacokinetic Modeling and Bayesian Estimators
33. Outcomes of Kidney Transplantation in Former Non Kidney Solid Organ Transplant
34. A Simple Strategy for Diagnosis of PTDM in Stable Kidney Transplanted Patients
35. First Scandinavian Protocol for Controlled Donation After Circulatory Death Using Normothermic Regional Perfusion
36. First Scandinavian Protocol for Controlled Donation After Circulatory Death Using Normothermic Regional Perfusion
37. The Authors’ Reply
38. Estimating Glomerular Filtration Rate in Kidney Transplant Recipients: Comparing a Novel Equation With Commonly Used Equations in this Population
39. Haptoglobin 2-2 Genotype, Patient, and Graft Survival in Renal Transplant Recipients
40. How to Report and Interpret Bioequivalence Data in Solid Organ Transplant Recipients
41. Mycophenolate Acid and Balancing the Risk for Male Allograft Recipients
42. Chronic musculoskeletal complaints as a predictor of mortality—The HUNT study
43. Mortality risk in post-transplantation diabetes mellitus based on glucose and HbA1c diagnostic criteria
44. Visceral fat is better related to impaired glucose metabolism than body mass index after kidney transplantation
45. Uric acid and clinical correlates of endothelial function in kidney transplant recipients
46. Improved prediction of tacrolimus concentrations early after kidney transplantation using theory-based pharmacokinetic modelling
47. Short-term efficacy and safety of sitagliptin treatment in long-term stable renal recipients with new-onset diabetes after transplantation
48. Inclusion of CYP3A5 genotyping in a nonparametric population model improves dosing of tacrolimus early after transplantation
49. UGT1A1*28 is Associated with Decreased Systemic Exposure of Atorvastatin Lactone
50. Long-term outcomes after cyclosporine or mycophenolate withdrawal in kidney transplantation – results from an aborted trial
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.